Pelthos Therapeutics Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2023 | $-173.4K | $-173.4K | — | $272.2K |
| Jun 2023 | $-193.6K | $-193.6K | — | $327.3K |
| Sep 2023 | $-257.2K | $-257.2K | — | $342.4K |
| Dec 2023 | $-356.8K | $-356.8K | — | $791.2K |
| Mar 2024 | $-2.0M | $-2.0M | — | $292.6K |
| Jun 2024 | $-3.0M | $-3.0M | — | $459.0K |
| Sep 2024 | $-177.7K | $-177.7K | — | $517.5K |
| Dec 2024 | $-670.0K | $-670.0K | — | $530.0K |
| Mar 2025 | $-632.0K | $-632.0K | $0 | $486.0K |
| Jun 2025 | $-447.0K | $-447.0K | $0 | $413.0K |
| Sep 2025 | $-15.3M | $-15.3M | — | $2.8M |
| Dec 2025 | $-6.3M | $-6.3M | — | $1.8M |
| Mar 2026 | $-13.1M | $-13.3M | $194.0K | $1.9M |
| Jun 2026 | $-7.7M | $-7.7M | $2.0K | $2.8M |